Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:
”During International Plasma Awareness Week, we honor the unseen heroes – plasma donors – and the life-changing impact of their generosity.
The Plasma Protein Therapeutics Association has designated “Plasma Powers Possibility” as this year’s theme, which speaks to the courage of patients and the compassion of those who help them.
At BioLife Plasma Services, our employees know that every donation could mean a better tomorrow for someone who relies on medicine made from plasma.
I want to thank all our employees for their commitment to creating a safe, comfortable, and convenient plasma donation experience for our donors every day.”
Takeda shared on LinkedIn:
”International Plasma Awareness Week (IPAW) is here!
This week, we shine a light on the vital importance of plasma donation, and its life-changing impact on individuals living with rare and serious conditions around the world.
For hundreds of thousands of people globally, medicines made from plasma are essential – and often, their only treatment option.
Plasma’s availability depends on the generosity of donors, making every plasma donation a precious gift.
See plasma’s journey from donor to patient below, and join us in championing this life-sustaining resource.”
Stay updated on the emerging with Hemostasis Today.
-
Oct 7, 2025, 08:27John Chuback - Blood Clots: The Silent Killer
-
Oct 7, 2025, 04:20Nita Radhakrishnan to Present The First Indian Collaborative Data on Hemophilia from the WBDR Registry
-
Oct 6, 2025, 17:51Klaus Mönkemüller Just Released "The EndoCollab Guide for GI Bleeding" For Endoscopists
-
Oct 6, 2025, 08:10Haemophilia Foundation Australia: Animals Can Have Bleeding Disorders Too!
-
Oct 6, 2025, 08:03Peter Libby: Exploring Inflammation in Atherosclerosis: Lessons and Therapeutic Implications
-
Oct 7, 2025, 08:31Brooke Wolford Leads Groundbreaking GWAS Study Identifying Novel Genetic Loci for Venous Thromboembolism
-
Oct 7, 2025, 08:25ImmuneLink LLC Research: Role of Interferon-Gamma (IFN-γ) in Pathophysiology and Management of Deep Vein Thrombosis
-
Oct 7, 2025, 03:56Nathan Connell: Interesting Data in The Management of HAC Has Been Published in Blood from Benoit Guillet and Colleagues
-
Oct 7, 2025, 03:40Nature Communications Study by Amelia Haj and Colleagues Identifies Factor XII as a Safer Target for Anticoagulation
-
Oct 7, 2025, 03:36Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots
-
Oct 6, 2025, 07:40Erin VanDyke: World Thrombosis Day Falls Right At The End Of PA Week, And It’s A Powerful Reminder Of Why I Do What I Do